These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 30178199)
1. F-18 fluoride uptake in primary breast cancer. Sarikaya I; Sharma P; Sarikaya A Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199 [TBL] [Abstract][Full Text] [Related]
2. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
3. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer. Arslan E; Çermik TF; Trabulus FDC; Talu ECK; Başaran Ş Nucl Med Commun; 2018 Jul; 39(7):680-690. PubMed ID: 29893750 [TBL] [Abstract][Full Text] [Related]
5. The value of quantitative analysis in Lapa P; Marques M; Costa G; Lima JP Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of primary tumor SUV Yoo J; Yoon HJ; Kim BS Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144 [TBL] [Abstract][Full Text] [Related]
7. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [ Azad GK; Taylor BP; Green A; Sandri I; Swampillai A; Harries M; Kristeleit H; Mansi J; Goh V; Cook GJR Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):821-830. PubMed ID: 30506455 [TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors. Karan B; Pourbagher A; Torun N J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655 [TBL] [Abstract][Full Text] [Related]
9. Prospective Study of Serial Peterson LM; O'Sullivan J; Wu QV; Novakova-Jiresova A; Jenkins I; Lee JH; Shields A; Montgomery S; Linden HM; Gralow J; Gadi VK; Muzi M; Kinahan P; Mankoff D; Specht JM J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233 [TBL] [Abstract][Full Text] [Related]
10. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262 [TBL] [Abstract][Full Text] [Related]
11. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis. Jung NY; Kim SH; Kang BJ; Park SY; Chung MH Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824 [TBL] [Abstract][Full Text] [Related]
13. Uptake of Radium-223 Dichloride and Early [ Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074 [TBL] [Abstract][Full Text] [Related]
14. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone-seeking novel radiotracer Passah A; Tripathi M; Ballal S; Yadav MP; Kumar R; Roesch F; Meckel M; Sarathi Chakraborty P; Bal C Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):41-49. PubMed ID: 27455986 [TBL] [Abstract][Full Text] [Related]
16. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients. Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190 [TBL] [Abstract][Full Text] [Related]
17. Increased FDG uptake in breast cancer is associated with prognostic factors. Sanli Y; Kuyumcu S; Ozkan ZG; Işik G; Karanlik H; Guzelbey B; Turkmen C; Ozel S; Yavuz E; Mudun A Ann Nucl Med; 2012 May; 26(4):345-50. PubMed ID: 22359222 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728 [TBL] [Abstract][Full Text] [Related]
20. Correlation of fluorine 18-labeled sodium fluoride uptake and arterial calcification on whole-body PET/CT in cancer patients. Dai D; Chuang HH; Macapinlac HA; Li T; Pan T Nucl Med Commun; 2019 Jun; 40(6):604-610. PubMed ID: 30688757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]